Feasibility study of new calibrators for thyroid-stimulating hormone (TSH) immunoprocedures based on remodeling of recombinant TSH to mimic glycoforms circulating in patients with thyroid disorders

Clinical Chemistry

Volumn 52, Issue 2, 2006, Pages 286-297

  Donadio, Sandrine ^a   Pascual, Aurélie ^a   Thijssen, Jos H H ^b   Ronin, Catherine ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FUCOSE; LECTIN; RECOMBINANT THYROTROPIN; SEPHAROSE; SIALIC ACID; SIALYLTRANSFERASE; THYROTROPIN; THYROXINE;

AFFINITY CHROMATOGRAPHY; ARTICLE; CALIBRATION; CONTROLLED STUDY; FEASIBILITY STUDY; FUCOSYLATION; GLYCOSYLATION; HUMAN; HYPOTHYROIDISM; IMMUNOASSAY; SERUM; SIALYLATION; STANDARD; THYROID DISEASE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

CALIBRATION; CHROMATOGRAPHY, AGAROSE; EPITOPES; FEASIBILITY STUDIES; FUCOSE; GLYCOSYLATION; HUMANS; HYPOTHYROIDISM; IMMUNOASSAY; PITUITARY GLAND; RECOMBINANT PROTEINS; REFERENCE STANDARDS; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SIALIC ACIDS; THYROTROPIN;

LENS CULINARIS;

EID: 31844431837     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.058172     Document Type: Article

References (50)

1. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem 1981;50:465-95.
2. Ronin C, Papandreou MJ, Sergi S, Labbe-Jullie C, Medri G, Hoffmann T, et al. Glycosylation-dependent epitope mapping of human TSH (hTSH) isoforms. Int J Rad Appl Instrum B 1990;17: 651-6.
3. Szkudlinski MW, Fremont V, Ronin C, Weintraub BD. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 2002;82:473-502.
4. Szkudlinski MW, Thotakura NR, Weintraub BD. Subunit-specific functions of N-linked oligosaccharides in human thyrotropin: role of terminal residues of α- and β-subunit oligosaccharides in metabolic clearance and bioactivity. Proc Natl Acad Sci USA 1995;92:9062-6.
5. Canonne C, Papandreou MJ, Medri G, Verrier B, Ronin C. Biological and immunochemical characterization of recombinant human thyrotrophin. Glycobiology 1995;5:473-81.
6. Cole ES, Lee K, Lauziere K, Kelton C, Chappel S, Weintraub B, et al. Recombinant human thyroid stimulating hormone: development of a biotechnology product for detection of metastatic lesions of thyroid carcinoma. Biotechnology (NY) 1993;11:1014-24.
7. Grabenhorst E, Schlenke P, Pohl S, Nimtz M, Conradt HS. Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells. Glycoconj J 1999;16:81-97.
8. Gerngross TU. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat Biotechnol 2004; 22:1409-14.
9. Grossmann M, Wong R, Teh NG, Tropea JE, East-Palmer J, Weintraub BD, et al. Expression of biologically active human thyrotropin (hTSH) in a baculovirus system: effect of insect cell glycosylation on hTSH activity in vitro and in vivo. Endocrinology 1997;138:92-100.
10. Miura Y, Perkel VS, Papenberg KA, Johnson MJ, Magner JA. Concanavalin-A, lentil, and ricin lectin affinity binding characteristics of human thyrotropin: differences in the sialylation of thyrotropin in sera of euthyroid, primary, and central hypothyroid patients. J Clin Endocrinol Metab 1989;69:985-95.
11. Papandreou MJ, Persani L, Asteria C, Ronin C, Beck-Peccoz P. Variable carbohydrate structures of circulating thyrotropin as studied by lectin affinity chromatography in different clinical conditions. J Clin Endocrinol Metab 1993;77:393-8.
12. Trojan J, Theodoropoulou M, Usadel KH, Stalla GK, Schaaf L. Modulation of human thyrotropin oligosaccharide structures-enhanced proportion of sialylated and terminally galactosylated serum thyrotropin isoforms in subclinical and overt primary hypothyroidism. J Endocrinol 1998;158:359-65.
13. Persani L, Borgato S, Romoli R, Asteria C, Pizzocaro A, Beck-Peccoz P. Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J Clin Endocrinol Metab 1998;83:2486-92.
14. Schaaf L, Trojan J, Helton TE, Usadel KH, Magner JA. Serum thyrotropin (TSH) heterogeneity in euthyroid subjects and patients with subclinical hypothyroidism: the core fucose content of TSH-releasing hormone-released TSH is altered, but not the net charge of TSH. J Endocrinol 1995;144:561-71.
15. Fiete D, Srivastava V, Hindsgaul O, Baenziger JU. A hepatic reticuloendothelial cell receptor specific for 304-4GalNAc β 1,4GlcNAc β 1,2Man α that mediates rapid clearance of lutropin. Cell 1991;67:1103-10.
16. Bianucci AM, Chiellini F. A 3D model for the human hepatic asialoglycoprotein receptor (ASGP-R). J Biomol Struct Dyn 2000; 18:435-51.
17. Joziasse DH, Lee RT, Lee YC, Biessen EA, Schiphorst WE, Koeleman CA, et al. α3-Galactosylated glycoproteins can bind to the hepatic asialoglycoprotein receptor. Eur J Biochem 2000;267: 6501-8.
18. Meier M, Bider MD, Malashkevich VN, Spiess M, Burkhard P. Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor. J Mol Biol 2000;300: 857-65.
19. Pricer WE Jr, Ashwell G. The binding of desialylated glycoproteins by plasma membranes of rat liver. J Biol Chem 1971;246:4825-33.
20. Pricer WE Jr, Hudgin RL, Ashwell G, Stockert RJ, Morell AG. A membrane receptor protein for asialoglycoproteins. Methods Enzymol 1974;34:688-91.
21. Townsend R, Stahl P. Isolation and characterization of a mannose/N-acetylglucosamine/fucose-binding protein from rat liver. Biochem J 1981;194):209-14.
22. Magnusson S, Berg T. Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells. Biochem J 1993;291:749-55.
23. Smedsrod B, Einarsson M. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver. Thromb Haemost 1990;63:60-6.
24. Lehrman MA, Haltiwanger RS, Hill RL. The binding of fucose-containing glycoproteins by hepatic lectins. The binding specificity of the rat liver fucose lectin. J Biol Chem 1986;261:7426-32.
25. Shimada T, Higashi K, Umeda T, Sato T. Thyroid functions in patients with various chronic liver diseases. Endocrinol Jpn 1988; 35:357-69.
26. L'age M, Meinhold H, Wenzel KW, Schleusener H. Relations between serum levels of TSH, TBG, T4, T3, rT3 and various histologically classified chronic liver diseases. J Endocrinol Invest 1980;3:379-83.
27. Agha F, Qureshi H, Khan RA. Serum thyroid hormone levels in liver cirrhosis. J Pak Med Assoc 1989;39:179-83.
28. Papandreou MJ, Sergi I, Benkirane M, Ronin C. Carbohydrate-dependent epitope mapping of human thyrotropin. Mol Cell Endocrinol 1990;73:15-26.
29. Sergi I, Papandreou MJ, Medri G, Canonne C, Verrier B, Ronin C. Immunoreactive and bioactive isoforms of human thyrotropin. Endocrinology 1991;128:3259-68.
30. Zerfaoui M, Ronin C. Glycosylation is the structural basis for changes in polymorphism and immunoreactivity of pituitary glycoprotein hormones. Eur J Clin Chem Clin Biochem 1996;34:749-53.
31. Kashiwai T, Ichihara K, Endo Y, Tamaki H, Amino N, Miyai K. Immunological and biological characteristics of recombinant human thyrotropin. J Immunol Methods 1991;143:25-30.
32. Donadio S, Morelle W, Pascual A, Romi-Lebrun R, Michalski JC, Ronin C. Both core and terminal glycosylation alter epitope expression in thyrotropin and introduce discordances in hormone measurements. Clin Chem Lab Med 2005;43:519-30.
33. Dayan CM. Interpretation of thyroid function tests. Lancet 2001; 357:619-24.
34. Wood WG, Waller D, Hantke U. An evaluation of six solid-phase thyrotropin (TSH) kits. J Clin Chem Clin Biochem 1985;23:461-71.
35. Carayon P, Martino E, Bartalena L, Grasso L, Mammoli C, Costagliola S, et al. Clinical usefulness and limitations of serum thyrotropin measurement by 'ultrasensitive' methods. Comparisons of five kits. Horm Res 1987;26:105-17.
36. Chan BY, Swaminathan R. Analytical and clinical performance of six sensitive thyrotrophin kits. Pathology 1990;22:11-5.
37. Laurberg P. Persistent problems with the specificity of immunometric TSH assays. Thyroid 1993;3:279-83.
38. Spencer CA, Takeuchi M, Kazarosyan M, MacKenzie F, Beckett GJ, Wilkinson E. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on variability of measurements of subnormal, concentrations of TSH. Clin Chem 1995;41:367-74.
39. Wood WG, Bruns U, Eber O, Langsteger W, Bounaud JY, Bounaud MP. Evaluation of the Abbott IMx ultrasensitive II hTSH immunometric assay in three European centres: a comparison with established commercial immunometric assays for thyrotropin. Eur J Clin Chem Clin Biochem 1996;34:151-8.
40. Rasmussen AK, Hilsted L, Perrild H, Christiansen E, Siersbaek-Nielsen K, Feldt-Rasmussen U. Discrepancies between thyrotropin (TSH) measurement by four sensitive immunometric assays. Clin Chim Acta 1997;259:117-28.
41. Price A, Burgin C, Catch I, Cruise M. Functional sensitivity and recovery of thyroid-stimulating hormone [Letter]. Clin Chem 2001; 47:2067.
42. Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf) 2003;58:138-40.
43. Rawlins ML, Roberts WL. Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin Chem 2004;50:2338-44.
44. Müller MM. Implementation of reference systems in laboratory medicine. Clin Chem 2000;46:1907-9.
45. Lequin RM. Standardization: comparability and traceability of laboratory results. Clin Chem 2002;48:391-3.
46. Legaigneur P, Breton C, El Battari A, Guillemot JC, Auge C, Malissard M, et al. Exploring the acceptor substrate recognition of the human β-galactoside β 2,6-sialyltransferase. J Biol Chem 2001;276:21608-17.
47. Donadio S, Pascual A, Dugas M, Ronin C. Standardisation des immunodosages de la TSH: production de nouveaux calibrateurs et harmonisation des tests. Immunoanal Biol Spé 2006; in press.
48. Rafferty B, Gaines Das R. Comparison of pituitary and recombinant human thyroid-stimulating hormone (rhTSH) in a multicenter collaborative study: establishment of the first World Health Organization reference reagent for rhTSH. Clin Chem 1999;45:2207-15.
49. Thotakura NR, Desai RK, Bates LG, Cole ES, Pratt BM, Weintraub BD. Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Endocrinology 1991;128:341-8.
50. Ribela MT, Bianco AC, Bartolini P. The use of recombinant human thyrotropin produced by Chinese hamster ovary cells for the preparation of immunoassay reagents. J Clin Endocrinol Metab 1996;81:249-56.